1,4-Anhydro-1,5-dihydroxy-Empagliflozin D4

1,4-Anhydro-1,5-dihydroxy-Empagliflozin D4 is a chemical compound that is used in pharmaceutical research. It is a deuterated derivative of empagliflozin, which is a medication used to treat type 2 diabetes. Empagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which reduces glucose reabsorption and increases glucose excretion in the urine. This results in lower blood glucose levels and improved glycemic control in patients with diabetes. 1,4-Anhydro-1,5-dihydroxy-Empagliflozin D4 is used in research to study the pharmacokinetics and metabolism of empagliflozin. The deuterated form of the compound is used to track the fate of empagliflozin in the body, as deuterium is a stable isotope that can be detected using mass spectrometry. This allows researchers to better understand how the drug is absorbed, distributed, metabolized, and eliminated from the body. Chemically, 1,4-Anhydro-1,5-dihydroxy-Empagliflozin D4 has a molecular formula of C23H21D4O8 and a molecular weight of 457.5 g/mol. It is a white or off-white powder that is soluble in water and organic solvents. The compound is stable under normal conditions, but should be stored in a cool and dry place away from light and moisture.